Standout Papers
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer (2011)
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial (2011)
- Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer (2010)
Immediate Impact
18 by Nobel laureates 16 from Science/Nature 122 standout
Citing Papers
Diagnosis and Treatment of Metastatic Colorectal Cancer
2021 Standout
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
2021 Standout
Works of Laslo Roman being referenced
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Laslo Roman | 4232 | 1285 | 1376 | 1324 | 31 | 5.0k | |
| Robert Mennel | 4106 | 1201 | 3226 | 679 | 47 | 6.5k | |
| Gorana Tomasic | 4340 | 1383 | 1264 | 525 | 63 | 5.9k | |
| Charles Ferté | 2400 | 1456 | 539 | 1492 | 77 | 4.1k | |
| Neville Davidson | 3634 | 1151 | 779 | 864 | 25 | 4.9k | |
| Beth Overmoyer | 4322 | 1250 | 1865 | 864 | 142 | 6.0k | |
| Dimosthenis Skarlos | 4753 | 2094 | 852 | 1019 | 103 | 6.2k | |
| Irene Kuter | 3338 | 1423 | 1043 | 1321 | 45 | 5.2k | |
| Robert Lim | 3023 | 1359 | 1046 | 331 | 52 | 4.4k | |
| Marcus Ballinger | 4914 | 2640 | 714 | 668 | 54 | 6.2k | |
| Cristina Oliva | 4700 | 1995 | 1035 | 1290 | 66 | 6.1k |
All Works
Loading papers...